Nextida GC decodes collagen to target post-meal spikes [Video]

An estimated 415 million people are currently living with diabetes worldwide, with that figure expected to rise to 642 million by 2040.¹ In the US, it is predicted that nearly 50% of adults will be obese by 2030.²

Amidst such concerning statistics, consumer focus on metabolic health is on the rise, with interest extending beyond weight management, as many individuals adopt a more preventative approach to health. And as consumers increasingly seek out natural and personalised solutions, the supplements and functional food and beverage markets are ripe for innovation in the trending glucose control space.

Enter Nextida GC, the first targeted collagen peptide product from Rousselot’s Nextida platform. Shown to significantly lower post-meal blood glucose spikes and boost GLP-1 secretion, Nextida GC delivers such health benefits in tandem with a sensory profile that make it well suited for all manner of functional foods and beverages, alongside supplements.

With research in this specialist field spanning more than 125 years, Rousselot is today a global leader in collagen-based solutions for the food, health and nutrition sectors. In this video, FoodTALKS learns more about the impressive trial outcomes that demonstrate the power of the company’s latest innovation to reduce post-meal blood glucose spikes in a natural way – thus contributing to an individual’s overall health, and opening up significant potential for formulators to leverage upon the hot topic of glucose control.

References